Skip to main content
TLPH logo

TLPH · Talphera, Inc. · Earnings Calls, Transcripts & Webcasts

Track TLPH — free
$0.79 +0.05 (+6.25%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$40.80M
Shares
51.96M
Volume · Nov 20 357.32K Avg daily vol (3M) 144.24K

Talphera, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Talphera, Inc. (TLPH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-11-12
Talphera, Inc. (TLPH) Q3 2026 Earnings Call Transcript
Positive tone Early study closure and FDA engagement Safety and clinical evidence Clinical trial enrollment challenges
Revenue
$0
▼ 100% YoY
EPS
$-0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-12
Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript
Confident tone NefroCRRT trial enrollment progress Product profile: ease of use and titration Commercial launch planning
Revenue
$0
EPS
$-0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript
Confident tone NEPHRO Study Enrollment Progress Nafamostat Clinical Advantages vs. Heparin/Citrate Cash Position and Financing
Revenue
$0
▼ 100% YoY
EPS
$-0.04
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-23
Talphera, Inc. (TLPH) Q4 2025 Earnings Call
Revenue
$0*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript
Positive tone Nephro study enrollment and site activation Financing and capital position Nefamostat product profile and commercial positioning
Revenue
$1,000
EPS
$-0.11
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript
Confident tone Niyad/nafamostat regulatory and clinical positioning Heparin and citrate shortages / market need New site profile strategy and site selection
Revenue
$0
EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript
Confident tone NEPHRO CRRT trial progress Compassionate use IDE Niyad commercial opportunity
Revenue
$27,000
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Talphera, Inc. (TLPH) Q4 2024 Earnings Call
Revenue
$0*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript
Positive tone NEPHRO CRRT registrational trial Trial execution shortfalls and remediation Regulatory pathway and FDA
Revenue
$0
▼ 100% YoY
EPS
$-0.13
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript
Positive tone Leadership transition and new Chief Development Officer NEPHRO study progress and site expansion Financial runway and capital position
Revenue
$0
▼ 100% YoY
EPS
$-0.15
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript
Positive tone Market opportunity and pricing for Niyad Niyad product profile vs. heparin and citrate NEPHRO CRRT study and enrollment
Revenue
$0
Diluted EPS
$-0.16
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-22
Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript
Positive tone Niyad registrational study Market opportunity for regional anticoagulant Corporate rebranding and governance
Net income
−$4.52M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Talphera, Inc. (TLPH) Q3 2023 Earnings Call Transcript
Revenue
$117,000
Diluted EPS
$-0.08
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Talphera, Inc. (TLPH) Q2 2023 Earnings Call Transcript
Revenue
$253,000
Diluted EPS
$-0.40
▼ 104.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Talphera, Inc. (TLPH) Q1 2023 Earnings Call Transcript
Net income
−$8.15M
EPS
$-0.75
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-30
Talphera, Inc. (TLPH) Q4 2022 Earnings Call
Revenue
−$442,000*
▼ 22200% YoY
Gross margin
181.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Talphera, Inc. (TLPH) Q3 2022 Earnings Call
Revenue
$0
▼ 100% YoY
Diluted EPS
$-0.94
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Talphera, Inc. (TLPH) Q2 2022 Earnings Call
Revenue
$0
▼ 100% YoY
Diluted EPS
$8.58
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Talphera, Inc. (TLPH) Q1 2022 Earnings Call
Revenue
$442,000
▼ 13.5% YoY
EPS
$-1.19
Gross margin
-77.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Talphera, Inc. (TLPH) Q4 2021 Earnings Call
Revenue
$2,000*
▼ 99.7% YoY
Gross margin
-61600.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-15
Talphera, Inc. (TLPH) Q3 2021 Earnings Call
Revenue
$1.86M
▲ 36.1% YoY
Diluted EPS
$-1.40
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
Talphera, Inc. (TLPH) Q2 2021 Earnings Call
Revenue
$443,000
▼ 84.8% YoY
Diluted EPS
$-1.60
Gross margin
-134.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Talphera, Inc. (TLPH) Q1 2021 Earnings Call
Revenue
$511,000
▲ 32.4% YoY
EPS
$-1.60
Gross margin
-103.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-15
Talphera, Inc. (TLPH) Q4 2020 Earnings Call
Revenue
$738,000*
▲ 55.4% YoY
Gross margin
-76.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Talphera, Inc. (TLPH) Q3 2020 Earnings Call
Revenue
$1.37M
▲ 125% YoY
Gross margin
-35.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
Talphera, Inc. (TLPH) Q4 2019 Earnings Call
Revenue
$475,000
▼ 22.5% YoY
Gross margin
-240.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–26 of 26 webcasts
Key facts CIK 1427925 CUSIP 00444T209 13F (30d) 57 filings 49 filers Visit website Investor relations